Skip to content
value.today

Avantra Biosciences Corp

🇺🇸 Woburn, Massachusetts, USABiotechnologyFounded 2009
Total raised
$30 M
5 rounds on record
Latest round
$3 M
Dec 2020
First round on record
Jul 2010
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Avantra Biosciences Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2020$3 MNo. 5$2 to $10 million

Avantra Biosciences Corp: Raise no. 5, Dec 2020

Investors in this round

65 investors had bought by the notice of Apr 7, 2021: 65 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brendan L McKernan · Executive Officer, Director
  • Kevin J. McKernan · Executive Officer
  • Patrick J. Costello · Executive Officer
  • Charles M Farkas · Director
  • Mark H DeBlois · Director
  • Philip J. Chapman · Director
  • Richard M McKernan · Director
  • Richard M Upton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Patrick Costello, Secretary. Newest notice filed Apr 7, 2021. Read the notice at the SEC.

equitySEC
Sep 2017$5 MNo. 4$2 to $10 million

Avantra Biosciences Corp: Raise no. 4, Sep 2017

Investors in this round

43 investors had bought by the notice of Nov 2, 2017: 43 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brendan L. McKernan · Executive Officer, Director
  • Kevin J. McKernan · Executive Officer
  • Patrick J. Costello · Executive Officer
  • Charles M. Farkas · Director
  • Mark H. DeBlois · Director
  • Philip J. Chapman · Director
  • Richard T. McKernan · Director
  • Richard T. Upton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Patrick Costello, Secretary. Newest notice filed Nov 2, 2017 (1 amendment). Read the notice at the SEC.

debt, optionsSEC
Jun 2015$8 MNo. 3$2 to $10 million

Avantra Biosciences Corp: Raise no. 3, Jun 2015

Investors in this round

3 investors had bought by the notice of Jun 15, 2015: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brendan L. McKernan · Executive Officer, Director · President
  • Patrick B. Costello · Executive Officer · Secretary
  • R. Brian McKernan · Executive Officer, Director · Chief Executive Officer
  • Emery G. Olcott · Director
  • John J. Altorelli · Director
  • Philip J. Chapman · Director
  • Richard J. Upton · Director
  • Richard T. McKernan · Director
  • Stephen M. McLean · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Patrick B. Costello, Secretary. Newest notice filed Jun 15, 2015. Read the notice at the SEC.

equitySEC
Oct 2011$8 MNo. 2$2 to $10 million

Avantra Biosciences Corp: Raise no. 2, Oct 2011

Investors in this round

67 investors had bought by the notice of Oct 7, 2011: 67 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brendan L. McKernan · Executive Officer, Director · President
  • John J. Altorelli · Executive Officer, Director · Secretary
  • Emery G. Olcott · Director
  • Philip J. Chapman · Director
  • Richard J. Upton · Director
  • Richard T. McKernan · Director
  • Stephen M. McLean · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by John J. Altorelli, Secretary. Newest notice filed Oct 7, 2011. Read the notice at the SEC.

equitySEC
Jul 2010$7 MNo. 1$2 to $10 million

Avantra Biosciences Corp: Raise no. 1, Jul 2010

Investors in this round

49 investors had bought by the notice of Aug 16, 2010: 49 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brendan L. McKernan · Executive Officer, Director · President
  • John J. Altorelli · Executive Officer, Director · Secretary
  • R. Brian McKernan · Executive Officer, Director · Chief Executive Officer
  • Philip M. Chapman · Director
  • Richard M. Upton · Director
  • Richard T. McKernan · Director
  • Stephen M. McLean · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by John J. Altorelli, Secretary. Newest notice filed Aug 16, 2010. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Avantra Biosciences Corp chose not to state its revenue in its newest notice of a funding round (Apr 2021).

    SEC Form D · Apr 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2021

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Avantra Biosciences Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Avantra Biosciences Corp
NameRoleNamed in
Brendan L McKernanExecutive officerApr 2021
Kevin J. McKernanExecutive officerApr 2021
Patrick J. CostelloExecutive officerApr 2021
Brendan L. McKernanExecutive officerNov 2017
Patrick B. CostelloSecretaryJun 2015
R. Brian McKernanChief Executive OfficerJun 2015
John J. AltorelliSecretaryOct 2011
Brendan L McKernanDirectorApr 2021
Charles M FarkasDirectorApr 2021
Mark H DeBloisDirectorApr 2021
Philip J. ChapmanDirectorApr 2021
Richard M McKernanDirectorApr 2021
Richard M UptonDirectorApr 2021
Brendan L. McKernanDirectorNov 2017
Charles M. FarkasDirectorNov 2017
Mark H. DeBloisDirectorNov 2017
Richard T. McKernanDirectorNov 2017
Richard T. UptonDirectorNov 2017
Emery G. OlcottDirectorJun 2015
John J. AltorelliDirectorJun 2015
R. Brian McKernanChief Executive OfficerJun 2015
Richard J. UptonDirectorJun 2015
Stephen M. McLeanDirectorJun 2015
Philip M. ChapmanDirectorAug 2010
Richard M. UptonDirectorAug 2010